Clinical Trials Directory

Trials / Completed

CompletedNCT01736137

Evaluation of the Six Minute Walk Test and Other Instruments in Heart Failure

Evaluation of the Six Minute Walk Test, Heart Rate Variability and Quality of Life in Heart Failure Patients on Beta-blocker Treatment

Status
Completed
Phase
Study type
Observational
Enrollment
17 (actual)
Sponsor
Federal University of Uberlandia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess functional capacity, quality of life and functioning of the autonomic nervous system in heart failure patients on beta-blocker treatment. The study hypothesis is that subjects who walk less distance, have lower quality of life and reduced heart rate variability during the six minute walk test.

Detailed description

Heart failure and its treatment result in symptoms such as pulmonary or systemic congestion causing impairment to the effort, psychological and social commitment, and impact on quality of life.

Conditions

Interventions

TypeNameDescription
OTHERSix minute walk testIf patients meet the criteria of the study, their data will be collected and will be interviewed to fill the Minnesota Living with Heart Failure Questionnaire (MLHFQ). They then will be taken to the hallway to perform the six minute walk test monitored with a heart rate monitor (Polar RS800 CX). After the test there will be a break of 20 to 30 minutes before repeating the walk test. During rest time, the patient will answer the general health survey questionnaire: Medical Outcome Study 36-item Short-Form Health Survey (SF-36).

Timeline

Start date
2011-11-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2012-11-29
Last updated
2014-08-07

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01736137. Inclusion in this directory is not an endorsement.